USX:VNRX - VolitionRX Ltd (USD 3.17) VolitionRx Limited
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 3.17    +0.060 (+1.93%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

2 Jun 2020


Overview

2 Jun 2020

Day Change: 0.060 (1.93%)

52 Wk Range: 2.22 - 6.84

Day's Range: 3.08 - 3.17

Last Volume: 168,290

Current Yield: 0%

Projected Yield: 0%

Open: USD 3.14

2 Jun 2020

Metric VNRX S.Median
Beta 1.03 0.45
VaR 49.09 55.02
E.Shortfall 68.64 89.56
Liquidity 141.14K 2,718.04

Fundamental

2 Jun 2020

PE: -7.738

Market Cap: 124.6M

Price Over Book: 8.774

Price Over Sales: -1,030.97

Return On Assets: -75.6%

Return On Equity: -113.4%

Current Ratio: 4.548

General

CEO: Dr. Martin Charles Faulkes

Headquarters: US

Employees: 50

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRx Limited is headquartered in Austin, Texas.